Publication | Closed Access

Macrophage activation markers predict mortality in patients with liver cirrhosis without or with acute-on-chronic liver failure (ACLF)

ImmunologyLiver CirrhosisPathologyFatty Liver DiseaseCirrhosisInflammationInflammatory MarkerChronic Liver FailureMacrophage Activation MarkersHepatology FibrosisAutoimmune DiseaseLiver PhysiologyAutoimmunityHepatology InflammationDrug-induced Liver InjuryAcute-on-chronic Liver FailureHepatologyAcute Liver FailureLiver DiseaseLiverMedicine